The OECD Competition Committee publishes background materials on excessive prices in pharmaceutical markets

There are strong arguments for not intervening against exploitative excessive pricing conducts, which have led to the development of stringent enforcement screens for the bringing

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • OECD - Competition Division (Paris)

Quotation

OECD, The OECD Competition Committee publishes background materials on excessive prices in pharmaceutical markets, 3 October 2018, e-Competitions October 2018, Art. N° 88369

Visites 1422

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues